LON:NMC - NMC Health Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0
+0 (0.00%)
Get New NMC Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NMC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NMC

Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for NMC Health in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of GBX 0. The average price target represents a NaN upside from the last price of GBX 0.

This chart shows the closing price for NMC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in NMC Health. This rating has held steady since February 2021, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/24/2020Jefferies Financial GroupLower Price TargetUnderperformGBX 1,300 ➝ GBX 500
1/21/2020Jefferies Financial GroupLower Price TargetUnderperformGBX 1,925 ➝ GBX 1,300
1/7/2020BarclaysReiterated RatingOverweight
12/18/2019BarclaysReiterated RatingOverweight
11/13/2019BarclaysReiterated RatingOverweightGBX 4,275
10/28/2019The Goldman Sachs GroupLower Price TargetBuyGBX 4,250 ➝ GBX 4,170
9/17/2019Berenberg BankBoost Price TargetBuyGBX 3,600 ➝ GBX 4,000
9/9/2019BarclaysReiterated RatingOverweight
8/27/2019Societe GeneraleReiterated RatingBuy
8/22/2019Berenberg BankReiterated RatingBuyGBX 3,600
8/9/2019BarclaysBoost Price TargetOverweightGBX 4,100 ➝ GBX 4,275
7/26/2019BarclaysReiterated RatingOverweight
7/9/2019Jefferies Financial GroupLower Price TargetUnderperformGBX 2,077 ➝ GBX 1,986
7/4/2019BarclaysLower Price TargetOverweightGBX 4,500 ➝ GBX 4,100
6/10/2019BarclaysReiterated RatingOverweight
5/28/2019Berenberg BankReiterated RatingBuyGBX 3,600
5/22/2019Jefferies Financial GroupLower Price TargetUnderperformGBX 2,300 ➝ GBX 2,077
5/3/2019Berenberg BankLower Price TargetBuyGBX 4,700 ➝ GBX 3,600
3/25/2019The Goldman Sachs GroupBoost Price TargetBuyGBX 4,230 ➝ GBX 4,240
3/11/2019BarclaysReiterated RatingOverweight
12/10/2018BarclaysReiterated RatingOverweightGBX 4,850
12/10/2018Berenberg BankReiterated RatingBuyGBX 5,400
11/27/2018Jefferies Financial GroupDowngradeUnderperformGBX 3,411 ➝ GBX 2,940
11/19/2018BarclaysReiterated RatingOverweightGBX 4,850
10/23/2018HSBCBoost Price TargetBuyGBX 1,430 ➝ GBX 4,600
10/9/2018BarclaysReiterated RatingOverweight
9/28/2018BarclaysReiterated RatingOverweight
9/21/2018BarclaysReiterated RatingOverweight
8/21/2018JPMorgan Chase & Co.Reiterated RatingNeutralGBX 3,270 ➝ GBX 4,060
8/20/2018Berenberg BankBoost Price TargetBuyGBX 4,600 ➝ GBX 5,400
8/20/2018BarclaysReiterated RatingTop pickGBX 4,600 ➝ GBX 4,850
8/7/2018BarclaysBoost Price TargetOverweightGBX 4,250 ➝ GBX 4,600
6/11/2018Berenberg BankReiterated RatingBuyGBX 4,600
5/14/2018Jefferies Financial GroupBoost Price TargetHoldGBX 3,085 ➝ GBX 3,291
4/23/2018BarclaysInitiated CoverageOverweightGBX 4,100 ➝ GBX 4,250
3/23/2018Berenberg BankBoost Price TargetBuyGBX 4,000 ➝ GBX 4,600
2/2/2018BarclaysInitiated CoverageOverweightGBX 4,100
1/29/2018Berenberg BankReiterated RatingBuyGBX 4,000
1/24/2018JPMorgan Chase & Co.DowngradeNeutralGBX 2,730 ➝ GBX 3,270
1/17/2018Jefferies Financial GroupReiterated RatingHoldGBX 3,085
12/20/2017Berenberg BankReiterated RatingBuyGBX 4,000
11/15/2017Jefferies Financial GroupReiterated RatingHoldGBX 2,810
10/6/2017Berenberg BankInitiated CoverageBuyGBX 4,000
10/3/2017Jefferies Financial GroupBoost Price TargetHoldGBX 2,450 ➝ GBX 2,810
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.13 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
12/7/2021
  • 2 very positive mentions
  • 5 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
1/6/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
2/5/2022
  • 0 very positive mentions
  • 12 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
3/7/2022
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 7 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/6/2022
  • 0 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
6/5/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
NMC Health logo
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers. The company has developed specialized verticals covering multi-specialty care, maternity and fertility, long-term and home care, operations and management, and distribution services. It is also involved in the distribution of pharmaceutical products, medical equipment, medical consumables and devices, education and office supplies, veterinary products, cosmetics, IT products, and rehab supplies, as well as consumer products, including personal care, food and beverages, household care, and home improvement products. The company was founded in 1975 and is based in London, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 23.57
Low: 0.05
High: 938.40

52 Week Range

Now: N/A

Volume

2,021,994 shs

Average Volume

480,652 shs

Market Capitalization

£10.44 million

P/E Ratio

0.04

Dividend Yield

1.93%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of NMC Health?

The following Wall Street sell-side analysts have issued research reports on NMC Health in the last year:
View the latest analyst ratings for NMC.

What is the current price target for NMC Health?

0 Wall Street analysts have set twelve-month price targets for NMC Health in the last year.
View the latest price targets for NMC.

What is the current consensus analyst rating for NMC Health?

NMC Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NMC.